Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry. hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.

Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry. hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. Part 2, Washington, DC, June 17, 1993 :

Saved in:
Bibliographic Details
Corporate Author: United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology (Author)
Format: Government Document Electronic eBook
Language:English
Published: Washington : U.S. Government Printing Office, 1993.
Series:U.S. Congressional documents. Congressional hearings.
Subjects:
Drug development > Government policy > United States.
Drugs > United States > Patents.
Research and development contracts, Government > United States.
Pharmaceutical industry > Government policy > United States.
Conflict of interests > United States.
Patents.
Online Access:CONNECT

Internet

CONNECT

Similar Items